Influence of age on prognosis of young patients with uveal melanoma: A matched retrospective cohort study

European Journal of Ophthalmology

Volumn 23, Issue 2, 2013, Pages 208-216

  Kaliki, Swathi ^a,b   Shields, Carol L ^a   Mashayekhi, Arman ^a   Ganesh, Anuradha ^a   Furuta, Minoru ^a   Shields, Jerry A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b L V PRASAD EYE INSTITUTE   (India)

Author keywords

Children; Eye; Melanoma; Metastasis; Pediatric; Prognosis; Tumor; Uvea

Indexed keywords

ADULT; AGE; ARTICLE; CANCER PROGNOSIS; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR LOCALIZATION; TUMOR VOLUME; UVEA MELANOMA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; IRIS NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; UVEAL NEOPLASMS; YOUNG ADULT;

EID: 84874169349     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/ejo.5000200     Document Type: Article

References (26)

1. Shields JA, Shields CL. Intraocular Tumors: An Atlas and Textbook, 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2008: 85-139.
2. Apt L. Uveal melanomas in children and adolescents. Int Ophthalmol Clin 1962; 2: 403-10.
3. Shields CL, Furuta M, Thangappan A, et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol 2009; 127: 989-98.
4. Singh AD, Shields CL, Shields JA. Prognostic factors in uveal melanoma. Melanoma Res 2001; 11: 255-63.
5. Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol 2006; 124: 1684-93.
6. Onken MD, Worley LA, Harbour JW. Association between gene expression profile, proliferation and metastasis in uveal melanoma. Curr Eye Res 2010; 35: 857-63.
7. Shields JA, Shields CL. Prognostic factors for uveal melanoma. In: Gospodarowicz M, O'Sullivan B, Sobin LH, eds. Prognostic Factors in Cancer, 3rd ed. Hoboken, NJ: Wiley-Liss, Inc.; 2006: 269-72.
8. Paul EV, Parnell BL, Fraker M. Prognosis of malignant melanomas of the choroid and ciliary body. Int Ophthalmol Clin 1962; 2: 387-402.
9. Barr CC, McLean IW, Zimmerman LE. Uveal melanoma in children and adolescents. Arch Ophthalmol 1981; 99: 2133-6.
10. Shields CL, Shields JA, Milite J, De Potter P, Sabbagh R, Menduke H. Uveal melanoma in teenagers and children. A report of 40 cases. Ophthalmology 1991; 98: 1662-6.
11. Pogrzebielski A, Orłowska-Heitzman J, Romanowska-Dixon B. Uveal melanoma in young patients. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1646-9.
12. Singh AD, Shields CL, Shields JA, Sato T. Uveal melanoma in young patients. Arch Ophthalmol 2000; 118: 918-23.
13. Leonard BC, Shields JA, McDonald PR. Malignant melanomas of the uveal tract in children and young adults. Can J Ophthalmol 1975; 10: 441-9.
14. Jensen OA. Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943-1952. Acta Ophthalmol 1982; 60: 161-82.
15. Verdaguer J Jr. Prepuberal and puberal melanomas in ophthalmology. Am J Ophthalmol 1965; 60: 1002-11.
16. Greer CH. Congenital melanoma of the anterior uvea. Arch Ophthalmol 1966; 76: 77-8.
17. Broadway D, Lang S, Harper J, et al. Congenital malignant melanoma of the eye. Cancer 1991; 67: 2642-52.
18. Ellsworth RM. Juvenile melanoma of the uvea. Trans Am Acad Ophthalmol Otolaryngol 1960; 64: 148-9.
19. Shields CL, Kaliki S, Furuta M, Mashayekhi A, Shields JA. Clinical spectrum and life prognosis of patients with uveal melanoma based on age at presentation in 8033 cases. Retina 2012; 32: 1363-72.
20. Shields CL, Kaliki S, Shah SU, Luo W, Furuta M, Shields JA. Iris melanoma: features and prognosis in 317 children and adults. J AAPOS 2012; 16: 10-6.
21. Diener-West M, Hawkins BS, Markowitz JA, Schachat AP. A review of mortality from choroidal melanoma. II. A metaanalysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 1992; 110: 245-50.
22. Strouse JJ, Fears TR, Tucker MA, Wayne AS. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol 2005; 23: 4735-41.
23. Ferrari A, Bono A, Baldi M, et al. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics 2005; 115: 649-54.
24. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19: 3622-34.
25. Nordlund JJ, Kirkwood JM, Forget BM, Milton G, Albert DM, Lerner AB. Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol 1983; 9: 689-96.
26. Sarici AM, Shah SU, Shields CL, Birdsong RH, Shields JA. Cutaneous halo nevi following plaque radiotherapy for uveal melanoma. Arch Ophthalmol 2011; 129: 1499-501.